California Public Employees Retirement System’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-86,709
| Closed | -$11.1M | – | 1101 |
|
|
2025
Q2 | $11.1M | Buy |
86,709
+9,153
| +12% | +$951K | 0.01% | 834 |
|
|
2025
Q1 | $6.86M | Sell |
77,556
-894
| -1% | -$87.2K | ﹤0.01% | 966 |
|
|
2024
Q4 | $6.84M | Sell |
78,450
-24,735
| -24% | -$2.27M | ﹤0.01% | 983 |
|
|
2024
Q3 | $9.54M | Buy |
103,185
+19,281
| +23% | +$1.92M | 0.01% | 927 |
|
|
2024
Q2 | $9.04M | Sell |
83,904
-4,821
| -5% | -$483K | 0.01% | 908 |
|
|
2024
Q1 | $8.42M | Buy |
88,725
+2,024
| +2% | +$174K | 0.01% | 951 |
|
|
2023
Q4 | $8M | Sell |
86,701
-4,525
| -5% | -$293K | 0.01% | 961 |
|
|
2023
Q3 | $4.58M | Hold |
91,226
| – | – | ﹤0.01% | 1090 |
|
|
2023
Q2 | $5.77M | Sell |
91,226
-4,609
| -5% | -$251K | ﹤0.01% | 1041 |
|
|
2023
Q1 | $4.31M | Sell |
95,835
-10,846
| -10% | -$489K | ﹤0.01% | 1112 |
|
|
2022
Q4 | $4.67M | Sell |
106,681
-5,265
| -5% | -$252K | ﹤0.01% | 1116 |
|
|
2022
Q3 | $7.38M | Hold |
111,946
| – | – | 0.01% | 996 |
|
|
2022
Q2 | $5.65M | Sell |
111,946
-12,078
| -10% | -$708K | 0.01% | 1051 |
|
|
2022
Q1 | $7.92M | Sell |
124,024
-5,998
| -5% | -$431K | 0.01% | 1030 |
|
|
2021
Q4 | $13.9M | Hold |
130,022
| – | – | 0.01% | 822 |
|
|
2021
Q3 | $13.4M | Sell |
130,022
-485
| -0.4% | -$45.2K | 0.01% | 857 |
|
|
2021
Q2 | $11.5M | Sell |
130,507
-129
| -0.1% | -$11.8K | 0.01% | 948 |
|
|
2021
Q1 | $12.7M | Buy |
130,636
+6,112
| +5% | +$610K | 0.01% | 917 |
|
|
2020
Q4 | $14M | Buy |
124,524
+9,624
| +8% | +$1.01M | 0.01% | 818 |
|
|
2020
Q3 | $10.7M | Buy |
114,900
+5,100
| +5% | +$393K | 0.01% | 810 |
|
|
2020
Q2 | $8.56M | Buy |
109,800
+4,200
| +4% | +$284K | 0.01% | 886 |
|
|
2020
Q1 | $6.17M | Buy |
105,600
+600
| +0.6% | +$38.6K | 0.01% | 917 |
|
|
2019
Q4 | $8.41M | Buy |
105,000
+13,000
| +14% | +$973K | 0.01% | 1086 |
|
|
2019
Q3 | $6.76M | Buy |
92,000
+38,500
| +72% | +$3.33M | 0.01% | 1084 |
|
|
2019
Q2 | $5.05M | Buy |
53,500
+5,700
| +12% | +$470K | 0.01% | 1110 |
|
|
2019
Q1 | $3.83M | Sell |
47,800
-8,170
| -15% | -$604K | ﹤0.01% | 1330 |
|
|
2018
Q4 | $3.02M | Sell |
55,970
-4,800
| -8% | -$292K | ﹤0.01% | 1450 |
|
|
2018
Q3 | $4.74M | Sell |
60,770
-4,069
| -6% | -$283K | 0.01% | 1350 |
|
|
2018
Q2 | $4.12M | Sell |
64,839
-11,760
| -15% | -$936K | 0.01% | 1429 |
|
|
2018
Q1 | $7.02M | Sell |
76,599
-5,551
| -7% | -$478K | 0.01% | 1114 |
|
|
2017
Q4 | $6.2M | Buy |
82,150
+72,953
| +793% | +$5.13M | 0.01% | 1224 |
|
|
2017
Q3 | $641K | Buy |
9,197
+2,997
| +48% | +$160K | ﹤0.01% | 2546 |
|
|
2017
Q2 | $314K | Buy |
+6,200
| New | +$263K | ﹤0.01% | 2832 |
|
Other funds holding BPMC
IA
HNB
California Public Employees Retirement System's BPMC Position: Q3 2025 in Review
California Public Employees Retirement System sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 86,709 shares — an estimated $11.1M sold.
California Public Employees Retirement System first reported a position in BPMC in Q2 2017 and held it in 33 quarters. The position peaked at $14M in Q4 2020. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.
- California Public Employees Retirement System reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
- California Public Employees Retirement System sold 86,709 Blueprint Medicines shares in Q3 2025, an estimated $11.1M.
- California Public Employees Retirement System first reported a position in Blueprint Medicines in Q2 2017 and held it in 33 quarters.
- California Public Employees Retirement System's Blueprint Medicines position peaked at $14M in Q4 2020.
- 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.
Based on California Public Employees Retirement System's 13F filing for Q3 2025, filed 14 Nov 2025.